The acquisition of Helvoet Polymer Technologies for EUR 90 million strengthens medical manufacturing capabilities, expands the global footprint in Europe and India, and is expected to be accretive to earnings by fiscal 2027. Integration and synergy realization are already underway.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.